Prof. Dr. Steffen Berweck, the esteemed chief physician of the large neuropedic department in Vogtareuth for 15 remarkable years, is poised to continue his impactful journey in the field of neuropediatrics. His leadership has already played a pivotal role in shaping Vogtareuth's exceptional reputation, and as he looks ahead, we can expect further advancements in neuropediatric care across the region.

Beginning his career at the University Hospital of Freiburg, Prof. Berweck developed a keen interest in neuropediatrics that will undoubtedly continue to drive his future initiatives. Anticipation builds as he prepares to enhance the implementation of innovative treatments, such as botulinum toxin therapy for children with cerebral palsy, and as he plans to expand educational courses on sonography-guided injections.

His expertise as a leading specialist in epileptology suggests that we are on the cusp of exciting developments that could significantly benefit children facing these challenges in the future. The contributions of Prof. Berweck are sure to have a lasting impact, and we eagerly await the new heights he will reach in the coming years.

Title: 

„Epilepsy and prognosis for seizures in children with cerebral palsy and white matter injuries."